Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Drug Safety|January 5, 2019
Managing Risks with Immune Therapies in Multiple SclerosisMoritz Förster, Patrick Küry, Orhan Aktas, et al.
Frontiers in Neurology|November 15, 2021
Case Report: Persisting Lymphopenia During Neuropsychiatric Tumefactive Multiple Sclerosis Rebound Upon Fingolimod WithdrawalValeria Koska, Moritz Förster, Katja Brouzou, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2009
p57kip2 is dynamically regulated in experimental autoimmune encephalomyelitis and interferes with oligodendroglial maturationDavid Kremer, André Heinen, Janusz Jadasz, et al.
Stem Cells and Development|November 27, 2009
Deciphering the oligodendrogenic program of neural progenitors: cell intrinsic and extrinsic regulatorsFrancisco J Rivera, Carolin Steffenhagen, David Kremer, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 3, 2012
Vinpocetine inhibits oligodendroglial precursor cell differentiationKlintsy Julieta Torres, Peter Göttle, David Kremer, et al.
Regional Anesthesia and Pain Medicine|June 25, 2011
Midazolam activates the intrinsic pathway of apoptosis independent of benzodiazepine and death receptor signalingMarkus F Stevens, Robert Werdehausen, Nina Gaza, et al.
Anesthesiology|December 3, 2011
Lidocaine metabolites inhibit glycine transporter 1: a novel mechanism for the analgesic action of systemic lidocaine?Robert Werdehausen, David Kremer, Timo Brandenburger, et al.
International Journal of Molecular Sciences|November 11, 2022
Siponimod Modulates the Reaction of Microglial Cells to Pro-Inflammatory StimulationJoel Gruchot, Ferdinand Lein, Isabel Lewen, et al.
Plos One|August 17, 2013
Mesenchymal stem cell conditioning promotes rat oligodendroglial cell maturationJanusz Joachim Jadasz, David Kremer, Peter Göttle, et al.
Pageof 6